Main > NEUROLOGY. > Multiple Sclerosis>Walking Improve. > Treatment > Co: USA. A. Dalfampridine ER Tab.

---

Co: USA. A. Dalfampridine ER Tab.'s subsections
(*) USA Approval Date: 2010. 01.22
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2017. 03.07.
TradeMark
TradeMark Web-Site

Co: USA. A. Dalfampridine ER Tab.'s products
This section has no products